| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.07 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.094 | 0.08 |